PREVYMIS

Identification of Prevymis

No description

Google image searchProduct monograph

Active ingredient

letermovir, 240 MG

DIN: 02469375

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: MERCK CANADA INC

Date: 20-DEC-2017

ATC:

• J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
• J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
• J05AX — Other antivirals (ATC, ATC/DDD)

External Links for Prevymis

Search on Google

• Prevymis side effects
• Prevymis dosage
• letermovir side effects
• letermovir dosage

Merck Canada Inc

Go to Merck website to see drug product details. Sometimes you can find prevymis photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.